SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-16-000917
Filing Date
2016-05-20
Accepted
2016-05-20 16:07:54
Documents
1
Period of Report
2016-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_3962.html 4  
1 PRIMARY DOCUMENT doc4_3962.xml 4 18526
  Complete submission text file 0001638599-16-000917.txt   19923
Mailing Address C/O INNOVIVE PHARMACEUTICALS, INC. 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Pfaffle Antony (Reporting) CIK: 0001368953 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34673 | Film No.: 161666260

Mailing Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921 908-517-9500
CorMedix Inc. (Issuer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations